The site will be unavailable from 11:00 PM GMT on Tuesday, 21 July 2026, until 4:00 AM GMT on Wednesday, 22 July 2026, due to scheduled maintenance.

Geriatrics

This is a plain language summary of an article published inthe journal Brain. People with Alzheimer’s disease may receivetreatments that target amyloid-β – a protein in the brain thatis one of the key characteristics of Alzheimer’s disease whenit is present in higher levels than normal. This article is aboutamyloid-related imaging abnormalities (ARIA), which can beadverse events for people with Alzheimer’s disease receivingantibody treatments targeting amyloid-β (known as anti–amyloid-β antibody treatments). This article also discusses waysto identify and manage ARIA.

26th Jun 2024

A plain language summary discussing amyloid-related imaging abnormalities (ARIA) and their characteristics